Skip to main content
Premium Trial:

Request an Annual Quote

Strata Develops Gene Validation Technology


ALAMEDA, Calif.--Strata Biosciences, a privately funded genomics company here, said it has developed proprietary tools with the capacity to knock out 100 genes per month using multiple vector systems, in an effort to attach functional relevance to gene sequences, discover disease-relevant genes, validate targets, and determine gene members of biological pathways.

Douglas Lane, Strata's president and CEO, remarked, "The pharmaceutical industry has invested more than $3.8 billion in gene discovery to find targets for drugs, but with the 135,000 presumed discovered genes, all but a few hundred have no known, confirmed functional relevance in disease."

Lane said his company is working to discover thousands of targets within the next three years by analyzing hundreds of thousands of genes implicated in each investigated disease process.

He added that Strata will "initially focus on major killers, including prostate and ovarian cancer, and a better understanding of immune regulation."

Filed under

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.